How the Blood-Brain Barrier Works: Protection and Function

Discover how the blood-brain barrier selectively controls what enters the brain, its cellular structure, and its role in neurological disease and drug delivery.

The InfoNexus Editorial TeamMay 7, 20269 min read

What Is the Blood-Brain Barrier?

The blood-brain barrier (BBB) is a highly selective semipermeable border that separates the circulating blood from the brain's extracellular fluid and the central nervous system (CNS). It is formed primarily by specialized endothelial cells lining the capillaries of the brain, assisted by astrocyte end-feet, pericytes, and the surrounding basement membrane. Together, these components create a tightly regulated microenvironment that protects the brain from pathogens, toxins, and fluctuations in blood chemistry, while ensuring a steady supply of nutrients and oxygen. The concept of a brain-specific barrier was first proposed by Paul Ehrlich in 1885, when he observed that intravenously injected dyes stained all organs except the brain and spinal cord.

Cellular Architecture of the BBB

The BBB is not a single structure but a multicellular complex. Each component plays a distinct role:

  • Brain endothelial cells: Unlike endothelial cells elsewhere in the body, brain capillary endothelial cells are joined by highly restrictive tight junctions (zonula occludens), which physically block the paracellular (between-cell) passage of most molecules.
  • Tight junction proteins: Claudins (especially claudin-5), occludin, and junctional adhesion molecules (JAMs) form the molecular seal between adjacent endothelial cells.
  • Astrocyte end-feet: Processes from astrocytes (star-shaped glial cells) envelop ~99% of the capillary surface, signaling endothelial cells to maintain barrier properties and regulating water transport via aquaporin-4 channels.
  • Pericytes: Contractile cells embedded in the basement membrane regulate blood flow, maintain tight junction integrity, and participate in immune surveillance.
  • Basement membrane: A sheet of extracellular matrix proteins (collagen IV, laminin, fibronectin) provides structural support and acts as an additional filtration layer.

How the BBB Controls Molecular Traffic

The BBB employs several mechanisms to regulate what enters and exits the brain:

  • Tight junction restriction: Prevents most polar and large molecules from crossing paracellularly. Small, lipid-soluble molecules (e.g., alcohol, many anesthetics) can diffuse directly through the endothelial cell membrane (transcellular).
  • Carrier-mediated transport: Glucose enters via GLUT1 transporters; amino acids use specific transporters (e.g., LAT1). This allows essential nutrients to cross despite the tight barrier.
  • Receptor-mediated transcytosis: Large molecules like insulin and transferrin bind specific receptors, are endocytosed, and transported across the cell in vesicles.
  • Efflux pumps: ATP-binding cassette (ABC) transporters — particularly P-glycoprotein (P-gp) — actively pump foreign molecules back into the blood, preventing accumulation of many drugs and toxins.

What the BBB Permits and Blocks

SubstanceCrosses BBB?Mechanism
Oxygen and CO2Yes (freely)Passive diffusion (lipid-soluble gases)
GlucoseYesCarrier-mediated transport (GLUT1)
EthanolYes (rapidly)Passive transcellular diffusion
Most antibioticsLimited or noEfflux pumps; hydrophilicity
Most bacteria and virusesBlocked normallyTight junctions; immune surveillance
InsulinYes (limited)Receptor-mediated transcytosis
Many chemotherapy drugsMinimalEfflux by P-glycoprotein

The BBB in Disease

BBB disruption is a feature of numerous neurological conditions. When tight junctions break down, immune cells and potentially harmful molecules enter the CNS, often worsening disease progression.

ConditionBBB Involvement
Multiple sclerosisImmune cells cross disrupted BBB, leading to myelin destruction
Alzheimer's diseaseBBB breakdown allows amyloid accumulation; pericyte loss contributes to vascular dysfunction
Stroke (ischemia)Hypoxia disrupts tight junctions, causing cerebral edema and hemorrhagic transformation
Bacterial meningitisBacterial toxins and cytokines loosen tight junctions, allowing pathogen entry
HIV encephalitisHIV-infected monocytes transmigrate across a compromised BBB

The BBB as a Drug Delivery Challenge

The same properties that make the BBB protective create a major obstacle for treating brain diseases. More than 98% of small-molecule drugs and nearly all large-molecule biopharmaceuticals cannot cross the BBB in therapeutically meaningful concentrations. Research strategies to overcome this include:

  • Lipophilic drug modification: Chemical alteration to increase solubility in lipid membranes.
  • Focused ultrasound: Temporarily and locally disrupts tight junctions using microbubbles to enable drug delivery.
  • Nanoparticles: Engineered carriers decorated with BBB-targeting ligands to trigger receptor-mediated transcytosis.
  • Intranasal delivery: Bypasses the BBB by traveling along olfactory and trigeminal nerve pathways directly to the brain.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for diagnosis and treatment.

neurosciencebrainphysiology

Related Articles